Effect of Flaxseed Oil Supplementation on the Erythrocyte Membrane Fatty Acid Composition and Endocannabinoid System Modulation in Patients With Coronary Artery Disease: A Double-Blind Randomized Controlled Trial

Effect of Flaxseed Oil Supplementation on the Erythrocyte Membrane Fatty Acid Composition and Endocannabinoid System Modulation in Patients With Coronary Artery Disease: A Double-Blind Randomized Controlled Trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سودا صالح قدیمی , محمد علی زاده , مسعود دارابی امین , علی گل محمدی , ثریا خیروری

کلمات کلیدی: CAD, Endocannabinoid, Flaxseed oil, CB1, CB2

نشریه: 12563 , 9 , 15 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله محمد علی زاده
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده تغذیه
کد مقاله 72465
عنوان فارسی مقاله Effect of Flaxseed Oil Supplementation on the Erythrocyte Membrane Fatty Acid Composition and Endocannabinoid System Modulation in Patients With Coronary Artery Disease: A Double-Blind Randomized Controlled Trial
عنوان لاتین مقاله Effect of Flaxseed Oil Supplementation on the Erythrocyte Membrane Fatty Acid Composition and Endocannabinoid System Modulation in Patients With Coronary Artery Disease: A Double-Blind Randomized Controlled Trial
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: The endocannabinoid system (ECS) overactivation, associated with increased inflammatory process, may act as a risk factor for coronary artery disease (CAD). Dietary fat may influence the ECS tone. The aim of the present study was to investigate the effect of flaxseed oil on the erythrocyte membrane fatty acid profile and ECS activity by the measurement of serum N-arachydonoil ethanolamine (AEA) and cannabinoid receptor type-1 (CB1), cannabinoid receptor type-2 (CB2), and fatty acid amide hydrolase (FAAH) mRNA expression. Methods: This clinical trial was performed on 44 patients with CAD. The intervention group received 1.5% fat milk supplemented with flaxseed oil (containing 2.5 g α-linolenic acid or ALA), while the placebo group received 1.5% fat milk for 10 weeks. The fatty acid profile of erythrocyte membrane phospholipids was measured by gas chromatography. The AEA level was determined using an ELISA kit, and real-time PCR was performed to measure CB1, CB2, and FAAH mRNA expression pre- and post-intervention. Results: Flaxseed oil supplementation resulted in a significant increase in the ALA content and a significant reduction in linoleic acid (LA) content of membrane phospholipids, compared to the placebo group (MD = − 0.35 and 2.89, respectively; P < 0.05). The within group analysis showed that flaxseed oil supplementation caused a significant reduction in both LA and arachidonic acid (MD = − 4.84 and − 4.03, respectively; P < 0.05) and an elevation in the ALA (MD = 0.37, P < 0.001) content of membrane phospholipids compared with the baseline. In the intervention group, a marked reduction was observed in the serum AEA level after 10 weeks of intervention, compared with the placebo group (MD = 0.64, P = 0.016). Changes in CB2 mRNA expression in the flaxseed oil group were significant (fold change = 1.30, P = 0.003), compared with the placebo group. Conclusion: Flaxseed oil supplementation could attenuate the ECS tone by decreasing the AEA level and increasing CB2 mRNA expression. Therefore, flaxseed oil may be considered a promising agent with cardioprotective properties.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سودا صالح قدیمیاول
محمد علی زادهدوم
مسعود دارابی امینچهارم
علی گل محمدیپنجم
ثریا خیروریششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Saleh-Ghadimi2020_Article_EffectOfFlaxseedOilSupplementa.pdf1399/03/19846428دانلود